Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Jun 8;13(11):1277-1287.
doi: 10.1016/j.jcin.2020.03.008.

Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes

Affiliations
Observational Study

Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes

Neel M Butala et al. JACC Cardiovasc Interv. .

Abstract

Objectives: The aims of this study were to examine variation in the use of conscious sedation (CS) for transcatheter aortic valve replacement (TAVR) across hospitals and over time and to evaluate outcomes of CS compared with general anesthesia (GA) using instrumental variable analysis, a quasi-experimental method to control for unmeasured confounding.

Background: Despite increasing use of CS for TAVR, contemporary data on utilization patterns are lacking, and existing studies evaluating the impact of sedation choice on outcomes may suffer from unmeasured confounding.

Methods: Among 120,080 patients in the TVT (Transcatheter Valve Therapy) Registry who underwent transfemoral TAVR between January 2016 and March 2019, the relationship between anesthesia choice and TAVR outcomes was evaluated using hospital proportional use of CS as an instrumental variable.

Results: Over the study period, the proportion of TAVR performed using CS increased from 33% to 64%, and CS was used in a median of 0% and 91% of cases in the lowest and highest quartiles of hospital CS use, respectively. On the basis of instrumental variable analysis, CS was associated with decreases in in-hospital mortality (adjusted risk difference: 0.2%; p = 0.010) and 30-day mortality (adjusted risk difference: 0.5%; p < 0.001), shorter length of hospital stay (adjusted difference: 0.8 days; p < 0.001), and more frequent discharge to home (adjusted risk difference: 2.8%; p < 0.001) compared with GA. The magnitude of benefit for most endpoints was less than in a traditional propensity score-based approach, however.

Conclusions: In contemporary U.S. practice, the use of CS for TAVR continues to increase, although there remains wide variation across hospitals. The use of CS for TAVR is associated with improved outcomes (including reduced mortality) compared with GA, although the magnitude of benefit appears to be less than in previous studies.

Keywords: TAVR; anesthesia; aortic stenosis; outcomes; variation.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1. Percentage of Transcatheter Aortic Valve Replacement Sites Using Conscious Sedation During Valve Implantation by Calendar Quarter
Over the study period, the proportion of sites performing at least one transcatheter aortic valve replacement procedure using conscious sedation increased gradually from 50.1% to 76.4%.
FIGURE 2
FIGURE 2. Variation in the Use of Conscious Sedation Across Hospitals in Patients Undergoing Percutaneous Transfemoral TAVR
(A) Variation in the use of conscious sedation over the entire study period. (B) Variation in the use of conscious sedation between April 2018 and March 2019. TAVR ¼ transcatheter aortic valve replacement.
CENTRAL ILLUSTRATION
CENTRAL ILLUSTRATION. Percentage of Transcatheter Aortic Valve Replacement Patients Receiving Conscious Sedation During Valve Implantation by Calendar Quarter
Between January 1, 2016 and March 31, 2019, the proportion of patients undergoing transcatheter aortic valve replacement using conscious sedation increased from 33.4% to 64.1%.

Comment in

References

    1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106: 3006–8. - PubMed
    1. Wood DA, Lauck SB, Cairns JA, et al. The Vancouver 3M (Multidisciplinary, Multimodality, but Minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: the 3M TAVR study. J Am Coll Cardiol Intv 2019;12:459–69. - PubMed
    1. Attizzani GF, Patel SM, Dangas GD, et al. Comparison of local versus general anesthesia following transfemoral transcatheter self-expanding aortic valve implantation (from the Transcatheter Valve Therapeutics Registry). Am J Cardiol 2019;123:419–25. - PubMed
    1. Hyman MC, Vemulapalli S, Szeto WY, et al. Conscious sedation versus general anesthesia for transcatheter aortic valve replacement: insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circulation 2017;136:2132–40. - PubMed
    1. Thiele H. A 2×2 randomized trial of self-expandable vs balloon-expandable valves and general vs local anesthesia in patients undergoing transcatheter aortic valve implantation. Presented at: Transcatheter Cardiovascular Therapeutics; 2018; San Diego, CA.

Publication types

MeSH terms